Reports in the literature show that low levels of p27 are present in prostate intraepithelial neoplasia, breast cancer, premalignant and malignant non-invasive lesions such as breast carcinoma in situ as well as cervical carcinoma and metastatic tumors. Here, CDKN1B is linked to breast cancer.